Patent · US Active

Substituted thiazolopyrimidines

US9675612B2 · kind B2 · utility

0Cited by

3References

11Claims

0Family size

Assignee

Bayer Pharma Aktiengesellschaft · DE

Inventors

Ulrich Klar · Berlin, DE
Lars Wortmann · Berlin, DE
Keith Graham · Berlin, DE
Florian Puehler · Wellesley, US
Detlev Sülzle · Berlin, DE
Georg Kettschau · Berlin, DE
Philip Lienau · Berlin, DE

Key dates

Filing date	Mar 3, 2014
Grant date	Jun 13, 2017
Priority date	—
Expiry date	Mar 4, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to substituted thiazolopyrimidine compounds of general formula I as described and defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.